<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="correction"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Ophthalmol</journal-id><journal-id journal-id-type="iso-abbrev">Clin Ophthalmol</journal-id><journal-id journal-id-type="publisher-id">Clinical Ophthalmology</journal-id><journal-title-group><journal-title>Clinical Ophthalmology (Auckland, N.Z.)</journal-title></journal-title-group><issn pub-type="ppub">1177-5467</issn><issn pub-type="epub">1177-5483</issn><publisher><publisher-name>Dove Medical Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29845978</article-id><article-id pub-id-type="pmc">5963829</article-id><article-id pub-id-type="doi">10.2147/OPTH.S168970</article-id><article-id pub-id-type="publisher-id">opth-12-913</article-id><article-categories><subj-group subj-group-type="heading"><subject>Corrigendum</subject></subj-group></article-categories><title-group><article-title>Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial [Corrigendum]</article-title></title-group><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>17</day><month>5</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>17</day><month>5</month><year>2018</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>12</volume><fpage>913</fpage><lpage>913</lpage><permissions><copyright-statement>&#x000a9; 2018 Nichols et al. This work is published and licensed by Dove Medical Press Limited</copyright-statement><copyright-year>2018</copyright-year><license><license-p>The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution &#x02013; Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.</license-p></license></permissions></article-meta></front><body><p>Nichols KK, Holland E, Toyos MM, et al. Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial. <italic>Clin Ophthalmol</italic>. 2018;12:<related-article related-article-type="corrected-article" id="d35e61" vol="12" page="263" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="29440868" ext-link-type="pubmed">263&#x02013;270</related-article>.</p><p>On page 266, both mentions of Figure 3, should be <xref ref-type="fig" rid="f4-opth-12-913">Figure 4</xref>.</p><p>On page 267, <xref ref-type="fig" rid="f4-opth-12-913">Figure 4</xref> is drawn incorrectly, the correct figure appears below:</p></body><floats-group><fig id="f4-opth-12-913" position="float"><label>Figure 4</label><caption><p>Drop comfort scores at 5, 10, and 15 minutes postinstillation among participants with drop comfort score &#x0003e;3 at 3-minute assessment (safety population; numbers above bars indicate participant numbers).</p><p><bold>Note:</bold> Drop comfort score (scale, 0&#x02013;10; 0 = very comfortable, 10 = very uncomfortable); drop discomfort corresponds to scores &#x0003e;3.</p></caption><graphic xlink:href="opth-12-913Fig4"/></fig></floats-group></article>